Tacrolimus-eluting stent inhibits neointimal hyperplasia via calcineurin/NFAT signaling in porcine coronary artery model |
| |
| Authors: | Narisato Hamada Masaaki Miyata Hideyuki Eto Takahiro Shirasawa Yuichi Akasaki Aya Nagaki Chuwa Tei |
| |
| Affiliation: | 1. Key Laboratory for Animal Genetics, Breeding, Reproduction and Molecular Design of Jiangsu Province, College of Animal Science and Technology, Yangzhou University, Yangzhou, Jiangsu, PR China;2. College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, PR China;1. Dept. of Experimental Medicine, Second University of Naples, Italy;2. Dept. of Cardiothoracic and Respiratory Sciences, Second University of Naples, Italy;3. Dept. of Anesthesiological, Surgical and Emergency Sciences, Second University of Naples, Italy;4. Excellence Research Centre for Cardiovascular Diseases, Second University of Naples, Italy;5. Dept. of Experimental Medical Science, Lund University, Sweden;6. Dept. of Clinical Science, Lund University, Sweden |
| |
| Abstract: | AimsThe purpose is to elucidate the mechanism by which a newly developed tacrolimus-eluting stent (TES) prevents neointimal hyperplasia after stenting.Methods and resultsThe three major coronary arteries in juvenile swine were randomized to implantation of either a TES or bare metal stent (BMS). Twelve weeks after stenting, the TES showed 29% less neointimal area than the BMS. Immunohistochemical staining showed that the expression of calcineurin was up-regulated in the neointima and media after stenting, and the TES inhibited this up-regulation. Western blotting demonstrated that the expression of calcineurin, nuclear factor of activated T cell (NFAT), and interleukin-2 (IL-2) was lower with the TES than with the BMS. To confirm the effect of tacrolimus on vascular smooth muscle cells (VSMCs) and its mechanism, cultured rat VSMCs were incubated with 12.5 μM of tacrolimus (tacrolimus group) or without tacrolimus (control group). The cell number of the tacrolimus group was significantly lower than that of the control group at 48 h of incubation. Western blotting demonstrated that tacrolimus decreased the expression of calcineurin, NFATc4, and IL-2 of cultured VSMCs. We confirmed that calcineurin small-interfering RNA (siRNA) decreased cell proliferation and the expression of NFATc4 and IL-2 in cultured VSMCs compared with negative control-siRNA.ConclusionThe newly developed TES inhibited neointimal hyperplasia after stenting via the calcineurin/NFAT/IL-2 signaling pathway, which is one of several mechanisms through which TES inhibits restenosis. Calcineurin may be an important molecular target to prevent restenosis after stenting. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
